Recent advances in unraveling the molecular mechanisms and functions of HOXA11‑AS in human cancers and other diseases (Review)
- Authors:
- Cheng Wei
- Liangjuan Zhao
- Hao Liang
- Yingwei Zhen
- Lei Han
-
Affiliations: Tianjin Neurological Institute, Key Laboratory of Post‑Neuroinjury Neuro‑Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital, Heping, Tianjin 300052, P.R. China, Tianjin Customs District China, Heping, Tianjin 300041, P.R. China, Department of Neurosurgery, The First Affliated Hospital of Zhengzhou University, Zhengzhou, Henan 453002, P.R. China - Published online on: March 19, 2020 https://doi.org/10.3892/or.2020.7552
- Pages: 1737-1754
-
Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y and Jiang X: PANDAR: A pivotal cancer-related long non-coding RNA in human cancers. Mol Biosyst. 13:2195–2201. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Q, Tai S and Wang J: Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. Pathol Res Pract. 215:843–848. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Adams BD, Parsons C, Walker L, Zhang WC and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest. 127:761–771. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human cells. Nature. 489:101–118. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P, Xu H, Xiao T, Cao Z, Peng J, et al: Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol. 34:1279–1286. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xue JY, Huang C, Wang W, Li HB, Sun M and Xie M: HOXA11-AS: A novel regulator in human cancer proliferation and metastasis. Onco Targets Ther. 11:4387–4393. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao W, Ma X, Liu L, Chen Q, Liu Z, Zhang Z, Ma S, Wang Z, Li H, Wang Z and Wu J: SNHG20: A vital lncRNA in multiple human cancers. J Cell Physiol. Jan 15–2019.(Epub ahead of print). doi: 10.1002/jcp.28143. | |
|
Schmitt AM and Chang HY: Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Anastasiadou E, Jacob LS and Slack FJ: Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Atianand MK, Caffrey DR and Fitzgerald KA: Immunobiology of long noncoding RNAs. Annu Rev Immunol. 35:177–198. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Khorkova O, Hsiao J and Wahlestedt C: Basic biology and therapeutic implications of lncRNA. Adv Drug Deliv Rev. 87:15–24. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Borsani G, Tonlorenzi R, Simmler MC, Dandolo L, Arnaud D, Capra V, Grompe M, Pizzuti A, Muzny D, Lawrence C, et al: Characterization of a murine gene expressed from the inactive X chromosome. Nature. 351:325–329. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Gendrel AV and Heard E: Noncoding RNAs and epigenetic mechanisms during X-chromosome inactivation. Annu Rev Cell Dev Biol. 30:561–580. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li ZX, Zhu QN, Zhang HB, Hu Y, Wang G and Zhu YS: MALAT1: A potential biomarker in cancer. Cancer Manag Res. 10:6757–6768. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Seiler J, Breinig M, Caudron-Herger M, Polycarpou-Schwarz M, Boutros M and Diederichs S: The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance. Nucleic Acids Res. 45:5458–5469. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ma M, Xu H, Liu G, Wu J, Li C, Wang X, Zhang S, Xu H, Ju S, Cheng W, et al: Metabolism-induced tumor activator 1 (MITA1), an Energy Stress-inducible long noncoding RNA, promotes hepatocellular carcinoma metastasis. Hepatology. 70:215–230. 2019.PubMed/NCBI | |
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen JJ, Chen WJ, Sun WY, Liu XM and Chen JB: lncRNA SNHG16 functions as an oncogene by sponging MiR-4518 and Up-regulating PRMT5 expression in Glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY, Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al: APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. J Clin Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu C, Cheng D, Qiu X, Zhuang M and Liu Z: Long noncoding RNA SNHG16 promotes cell proliferation by sponging MicroRNA-205 and upregulating ZEB1 expression in osteosarcoma. Cell Physiol Biochem. 51:429–440. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yan H, Li H, Li P, Li X, Lin J, Zhu L, Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. J Exp Clin Cancer Res. 37:2372018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J, Rao X, Li M, Sun M, Jiang M, et al: Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of Ephrin A1 by competitively binding GMAN-AS. Gastroenterology. 156:676–691.e11. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, et al: H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 45:3086–3101. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Peng WX, Koirala P and Mo YY: lncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S; Cancer Genome Atlas Research Network, ; Xie W and Yang D: lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes Cell-cycle progression in cancer. Cancer Cel. 33:706–720.e9. 2018. View Article : Google Scholar | |
|
Bhan A, Soleimani M and Mandal SS: Long noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YG, Satpathy AT and Chang HY: Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 18:962–972. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chu C, Zhang QC, da Rocha ST, Flynn RA, Bharadwaj M, Calabrese JM, Magnuson T, Heard E and Chang HY: Systematic discovery of Xist RNA binding proteins. Cell. 161:404–416. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Samata M and Akhtar A: Dosage compensation of the X chromosome: A complex epigenetic assignment involving chromatin regulators and long noncoding RNAs. Annu Rev Biochem. 87:323–350. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Vallot C, Patrat C, Collier AJ, Huret C, Casanova M, Liyakat AT, Tosolini M, Frydman N, Heard E, Rugg-Gunn PJ and Rougeulle C: XACT noncoding RNA competes with XIST in the control of X Chromosome activity during human early development. Cell Stem Cell. 20:102–111. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Furlan G, Gutierrez Hernandez N, Huret C, Galupa R, van Bemmel JG, Romito A, Heard E, Morey C and Rougeulle C: The Ftx noncoding locus controls X chromosome inactivation independently of its RNA products. Mol Cell. 70:462–472.e8. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Sarma K, Cifuentes-Rojas C, Ergun A, Del Rosario A, Jeon Y, White F, Sadreyev R and Lee JT: ATRX directs binding of PRC2 to Xist RNA and Polycomb targets. Cell. 159:869–883. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al: lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al: Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, McDonel PE, Guttman M and Lander ES: Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 539:452–455. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun TT, He J, Liang Q, Ren LL, Yan TT, Yu TC, Tang JY, Bao YJ, Hu Y, Lin Y, et al: lncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern. Cancer Discov. 6:784–801. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Liu X, Zhou J, Hu J, Zhang D, Liu J, Qiao Y and Zhan Q: Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis. Hepatology. 65:1612–1627. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Long Y, Wang X, Youmans DT and Cech TR: How do lncRNAs regulate transcription? Sci Adv. 3:eaao21102017. View Article : Google Scholar : PubMed/NCBI | |
|
Hu WL, Jin L, Xu A, Wang YF, Thorne RF, Zhang XD and Wu M: GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability. Nat Cell Biol. 20:492–502. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bhan A and Mandal SS: Estradiol-induced transcriptional regulation of long non-coding RNA, HOTAIR. Methods Mol Biol. 1366:395–412. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Grelet S, Link LA, Howley B, Obellianne C, Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: Addendum: A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 19:14432017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Q, Guo L, Jiang F, Li L, Li Z and Chen F: Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER-breast cancer cell lines. J Cell Mol Med. 19:2874–2887. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX, Wu ZH, Chen XW, Gao P, Miao ZF and Wang ZN: Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 8:2892017. View Article : Google Scholar : PubMed/NCBI | |
|
Shen L, Wang Q, Liu R, Chen Z, Zhang X, Zhou P and Wang Z: lncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA. Nucleic Acids Res. 46:717–729. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yu W, Peng W, Jiang H, Sha H and Li J: lncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells. Tumour Biol. 39:10104283177214402017. View Article : Google Scholar : PubMed/NCBI | |
|
Dhir A, Dhir S, Proudfoot NJ and Jopling CL: Microprocessor mediates transcriptional termination of long noncoding RNA transcripts hosting microRNAs. Nat Struct Mol Biol. 22:319–327. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Augoff K, McCue B, Plow EF and Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer. 11:52012. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Nangia-Makker P, Farhana L and Majumdar A: A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI | |
|
Villamizar O, Chambers CB, Riberdy JM, Persons DA and Wilber A: Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis. Oncotarget. 7:13810–13826. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Jadaliha M, Gholamalamdari O, Tang W, Zhang Y, Petracovici A, Hao Q, Tariq A, Kim TG, Holton SE, Singh DK, et al: A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability. PLoS Genet. 14:e10078022018. View Article : Google Scholar : PubMed/NCBI | |
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF, et al: Exosome-Transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rashid F, Shah A and Shan G: Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics. 14:73–80. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S, Huarte M, Zhan M, Becker KG and Gorospe M: LincRNA-p21 suppresses target mRNA translation. Mol Cell. 47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA, et al: A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 472:120–124. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
He RZ, Luo DX and Mo YY: Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes Dis. 6:6–15. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Han Z, Sun Z, Wang Y, Zheng M and Song C: lncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. J Exp Clin Cancer Res. 37:2222018. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Li T, Qu Y, Wang X, Li B, Song J, Sun X, Tang Y, Wan J, Yu Y, et al: Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression. Cancer Lett. 425:78–87. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cui M, Wang J, Li Q, Zhang J, Jia J and Zhan X: Long non-coding RNA HOXA11-AS functions as a competing endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p in osteosarcoma. Biomed Pharmacother. 92:437–444. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng LL, Li JH, Wu J, Sun WJ, Liu S, Wang ZL, Zhou H, Yang JH and Qu LH: deepBase v2.0: Identification, expression, evolution and function of small RNAs, lncRNAs and circular RNAs from deep-sequencing data. Nucleic Acids Res. 44:D196–D202. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Spencer DH, Young MA, Lamprecht TL, Helton NM, Fulton R, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Miller CA, et al: Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells. Leukemia. 29:1279–1289. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Garcia-Fernández J: The genesis and evolution of homeobox gene clusters. Nat Rev Genet. 6:881–892. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kelly ZL, Michael A, Butler-Manuel S, Pandha HS and Morgan RG: HOX genes in ovarian cancer. J Ovarian Res. 4:162011. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng W, Liu J, Yoshida H, Rosen D and Naora H: Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med. 11:531–537. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lu S, Jiang X, Su Z, Cui Z, Fu W and Tai S: The role of the long non-coding RNA HOXA11-AS in promoting proliferation and metastasis of malignant tumors. Cell Biol Int. 42:1596–1601. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu CW, Zhou DD, Xie T, Hao JL, Pant OP, Lu CB and Liu XF: HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers. Cancer Med. 7:3792–3799. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xu YJ, Du Y and Fan Y: Long noncoding RNAs in lung cancer: What we know in 2015. Clin Transl Oncol. 18:660–665. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kang CG, Lee HJ, Kim SH and Lee EO: Zerumbone suppresses Osteopontin-induced cell invasion through inhibiting the FAK/AKT/ROCK pathway in human Non-small cell lung cancer A549 cells. J Nat Prod. 79:156–160. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Osmani L, Askin F, Gabrielson E and Li QK: Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 52:103–109. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Xuan J, Song Y, Qi W, He B, Wang P and Qin L: Nanoporous Glass integrated in volumetric Bar-chart chip for Point-of-Care diagnostics of non-small cell lung cancer. Acs Nano. 10:1640–1647. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, He RQ, Dang YW, Zhang XL, Wang X, Huang SN, Huang WT, Jiang MT, Gan XN, Xie Y, et al: Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell Int. 16:892016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Chen WJ, Gan TQ, Zhang XL, Xie ZC, Ye ZH, Deng Y, Wang ZF, Cai KT, Li SK, et al: Clinical significance and effect of lncRNA HOXA11-AS in NSCLC: A study based on bioinformatics, in vitro and in vivo verification. Sci Rep. 7:5567–18. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Luo J, Wang X, Wang HL, Zhang XL, Gan TQ, Chen G and Luo DZ: A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells. Oncol Lett. 15:6147–6160. 2018.PubMed/NCBI | |
|
Chen JH, Zhou LY, Xu S, Zheng YL, Wan YF and Hu CP: Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer. Cancer Cell Int. 17:642017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao X, Li X, Zhou L, Ni J, Yan W, Ma R, Wu J, Feng J and Chen P: lncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3. Cancer Sci. 109:3068–3079. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu F, Yin Z, Yang L, Fan J, Xu J, Jin Y, Yu J, Zhang D and Yang G: Smoking induced extracellular vesicles release and their distinct properties in Non-small cell lung cancer. J Cancer. 10:3435–3443. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Vogel A, Cervantes A, Chau I, Daniele B, Llovet J, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, et al: Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 29 (Suppl 4):iv238–iv255. 2018. View Article : Google Scholar | |
|
Koeberle D, Dufour JF, Demeter G, Li Q, Ribi K, Samaras P, Saletti P, Roth AD, Horber D, Buehlmann M, et al: Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Ann Oncol. 27:856–861. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Tai WM, Yong WP, Lim C, Low LS, Tham CK, Koh TS, Ng QS, Wang WW, Wang LZ, Hartano S, et al: Ann A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC). Ann Oncol. 27:2210–2215. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ciuleanu T, Bazin I, Lungulescu D, Miron L, Bondarenko I, Deptala A, Rodriguez-Torres M, Giantonio B, Fox NL, Wissel P, et al: A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma. Ann Oncol. 27:680–687. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu B, Li J, Liu X, Zheng M, Yang Y, Lyu Q and Jin L: Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5. Oncotarget. 8:109509–109521. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu J, Hong JF, Kang J, Liao LH and Li CD: Promotion of lncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1. Eur Rev Med Pharmacol Sci. 21:3402–3411. 2017.PubMed/NCBI | |
|
Zhan M, He K, Xiao J, Liu F, Wang H, Xia Z, Duan X, Huang R, Li Y, He X, et al: lncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p. J Cell Mol Med. May 15–2018.(Epub ahead of print). doi: 10.1111/jcmm.13633. View Article : Google Scholar | |
|
Gusyatiner O and Hegi ME: Glioma epigenetics: From subclassification to novel treatment options. Semin Cancer Biol. 51:50–58. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen ZR, Ramishetti S, Peshes-Yaloz N, Goldsmith M, Wohl A, Zibly Z and Peer D: Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano. 9:1581–1591. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang KL, Han L, Chen LY, Shi ZD, Yang M, Ren Y, Chen LC, Zhang JX, Pu PY and Kang CS: Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas. Cancer Lett. 342:139–149. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Wang K, Han L, Zhang A, Shi Z, Zhang K, Zhang H, Yang S, Pu P, Shen C, et al: PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth. Cancer Lett. 331:211–219. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gonzalez-Quarante LH, Fernández Carballal C, Agarwal V, Vargas Lopez AJ, Gil de Sagredo Del Corral OL and Sola Vendrell E: Angiocentric Glioma in an elderly patient: Case report and review of the literature. World Neurosurg. 97:755.e5–755.e10. 2017. View Article : Google Scholar | |
|
Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, Pu P, Kang C and Han L: A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 373:251–259. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cui Y, Yi L, Zhao J and Jiang Y: Long Noncoding RNA HOXA11-AS functions as miRNA sponge to promote the glioma tumorigenesis through targeting miR-140-5p. DNA Cell Biol. 36:822–828. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu C, He T, Li Z, Liu H and Ding B: Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells. Biomed Pharmacother. 95:1504–1513. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu CH, Xiao LM, Liu Y, Chen LK, Zheng SY, Zeng EM and Li DH: The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2. Eur Rev Med Pharmacol Sci. 23:241–252. 2019.PubMed/NCBI | |
|
Yang JX, Liu B, Yang BY and Meng Q: Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p. Neoplasma. 65:505–514. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rychahou P, Haque F, Shu Y, Zaytseva Y, Weiss HL, Lee EY, Mustain W, Valentino J, Guo P and Evers BM: Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano. 9:1108–1116. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Cao F, Zhang G, Shi L, Chen S, Zhang Z, Zhi W and Ma T: Trends in and predictions of colorectal cancer incidence and mortality in china from 1990 to 2025. Front Oncol. 9:982019. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, et al: Effects of cancer stage and treatment differences on racial disparities in survival from colon cancer: A united states population-based study. Gastroenterology. 150:1135–1146. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li T, Xu C, Cai B, Zhang M, Gao F and Gan J: Expression and clinicopathological significance of the lncRNA HOXA11-AS in colorectal cancer. Oncol Lett. 12:4155–4160. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen D, Sun Q, Zhang L, Zhou X, Cheng X, Zhou D, Ye F, Lin J and Wang W: The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer. Oncotarget. 8:70642–70652. 2017.PubMed/NCBI | |
|
Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV and Mitsis M: Breast cancer in young women: An overview. Updates Surg. 69:313–317. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Leonard M, Shu Y, Yang Y, Shu D, Guo P and Zhang X: Overcoming Tamoxifen resistance of human breast cancer by targeted gene silencing using multifunctional pRNA nanoparticles. Acs Nano. 11:335–346. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lemler DJ, Lynch ML, Tesfay L, Deng Z, Paul BT, Wang X, Hegde P, Manz DH, Torti SV and Torti FM: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Res. 19:252017. View Article : Google Scholar : PubMed/NCBI | |
|
Borin TF, Arbab AS, Gelaleti GB, Ferreira LC, Moschetta MG, Jardim-Perassi BV, Iskander AS, Varma NR, Shankar A, Coimbra VB, et al: Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. J Pineal Res. 60:3–15. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
van Roosmalen W, Le Dévédec SE, Golani O, Smid M, Pulyakhina I, Timmermans AM, Look MP, Zi D, Pont C, de Graauw M, et al: Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. J Clin Invest. 125:1648–1664. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Su J and Hu X: Long non-coding RNA HOXA11-AS promotes cell proliferation and metastasis in human breast cancer. Mol Med Rep. 16:4887–4894. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Jia G, Qu Y, Du Q and Liu B and Liu B: Long Non-coding RNA (lncRNA) HOXA11-AS promotes breast cancer invasion and metastasis by regulating Epithelial-mesenchymal transition. Med Sci Monit. 23:3393–3403. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang K, Liang Q, Li X, Tsoi H, Zhang J, Wang H, Go MY, Chiu PW, Ng EK, Sung JJ and Yu J: MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. Gut. 65:1619–1631. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sugano K: Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 29:895–905. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He D, Xie M, Xu L, De W, Wang Z and Wang J: lncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Chen Z, Fan R, Jiang B, Chen X, Chen Q, Nie F, Lu K and Sun M: Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Mol Cancer. 16:822017. View Article : Google Scholar : PubMed/NCBI | |
|
Grignon DJ and Che M: Clear cell renal cell carcinoma. Clin Lab Med. 25:305–316. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, et al: Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 356:125–134. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ridge CA, Pua BB and Madoff DC: Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yang FQ, Zhang JQ, Jin JJ, Yang CY, Zhang WJ, Zhang HM, Zheng JH and Weng ZM: HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression. J Cell Physiol. 233:9611–9619. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, et al: Integrative analysis identifies four molecular and clinical subsets in Uveal melanoma. Cancer Cell. 32:204–220.e15. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Moore AR, Ceraudo E, Sher JJ, Guan Y, Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS, et al: Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat Genet. 48:675–680. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Coupland SE, Lake SL, Zeschnigk M and Damato BE: Molecular pathology of uveal melanoma. Eye (Lond). 27:230–242. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Q, Zhao N, Zha G, Wang H, Tong Q and Xin S: lncRNA HOXA11-AS exerts oncogenic functions by repressing p21 and miR-124 in Uveal melanoma. DNA Cell Biol. 36:837–844. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ignarski M, Islam R and Müller RU: Long Non-coding RNAs in Kidney disease. Int J Mol Sci. 20:E32762019. View Article : Google Scholar : PubMed/NCBI | |
|
Dong D, Mu Z, Zhao C and Sun M: ZFAS1: A novel tumor-related long non-coding RNA. Cancer Cell Int. 18:1252018. View Article : Google Scholar : PubMed/NCBI | |
|
Cheetham SW, Gruhl F, Mattick JS and Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA, Coppola D, Reid BM, Lin H, Teer JK, Berchuck A, Birrer MJ, et al: A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Steuer CE, El-Deiry M, Parks JR, Higgins KA and Saba NF: An update on larynx cancer. CA Cancer J Clin. 67:31–50. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qu L, Jin M, Yang L, Sun C, Wang P, Li Y, Tian L, Liu M and Sun Y: Expression of long non-coding RNA HOXA11-AS is correlated with progression of laryngeal squamous cell carcinoma. Am J Transl Res. 10:573–580. 2018.PubMed/NCBI | |
|
Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO, Kim KH, Lee JK, Kim SW and Kim YT: The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer. Oncotarget. 7:83001–83016. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sun XY, Wang XF, Cui YB, Cao XG, Zhao RH, Wei HY, Cao W and Wu W: Expression level and clinical significance of lncRNA HOXA11-AS in esophageal squamous cell carcinoma patients. Zhonghua Zhong Liu Za Zhi. 40:186–190. 2018.(In Chinese). PubMed/NCBI | |
|
Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang C, Inzana JA, Mirando AJ, Ren Y, Liu Z, Shen J, O'Keefe RJ, Awad HA and Hilton MJ: NOTCH signaling in skeletal progenitors is critical for fracture repair. J Clin Invest. 126:1471–1481. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wang XN, Zhang LH, Cui XD, Wang MX, Zhang GY and Yu PL: lncRNA HOXA11-AS is involved in fracture healing through regulating mir-124-3p. Eur Rev Med Pharmacol Sci. 21:4771–4776. 2017.PubMed/NCBI | |
|
Mirzakhani H, Litonjua AA, McElrath TF, O'Connor G, Lee-Parritz A, Iverson R, Macones G, Strunk RC, Bacharier LB, Zeiger R, et al: Early pregnancy vitamin D status and risk of preeclampsia. J Clin Invest. 126:4702–4715. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Powe CE, Levine RJ and Karumanchi SA: Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 123:2856–2869. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Wu D, Liu J, Huang S, Zuo Q, Xia X, Jiang Y, Wang S, Chen Y, Wang T and Sun L: Downregulated lncRNA HOXA11-AS affects trophoblast cell proliferation and migration by regulating RND3 and HOXA7 expression in PE. Mol Ther Nucleic Acids. 12:195–206. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hu L, Chang L, Zhang Y, Zhai L, Zhang S, Qi Z, Yan H, Yan Y, Luo X, Zhang S, et al: Platelets express activated P2Y12 receptor in patients with diabetes mellitus. Circulation. 136:817–833. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Jin QS, Huang LJ, Zhao TT, Yao XY, Lin LY, Teng YQ, Kim SH, Nam MS, Zhang LY and Jin YJ: HOXA11-AS regulates diabetic arteriosclerosis-related inflammation via PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 22:6912–6921. 2018.PubMed/NCBI | |
|
Grelet S, Link LA, Howley B, Obellianne C, Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 19:1105–1115. 2017. View Article : Google Scholar : PubMed/NCBI |
